Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH)

被引：0
|
作者：
Hilary M. DuBrock
Hayley D. Germack
Marjolaine Gauthier-Loiselle
Jörg Linder
Ambika Satija
Ameur M. Manceur
Martin Cloutier
Patrick Lefebvre
Sumeet Panjabi
Robert P. Frantz
机构：
[1] Mayo Clinic,
[2] Medical Affairs,undefined
[3] Johnson and Johnson Innovative Medicines,undefined
[4] Analysis Group,undefined
[5] Inc.,undefined
[6] Janssen-Cilag GmbH,undefined
[7] Analysis Group,undefined
[8] Inc.,undefined
来源：
PharmacoEconomics - Open | 2024年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：133 / 146
页数：13
相关论文
共 50 条
  • [21] Expert Council resolution on pulmonary arterial hypertension (PAH) "Changing the paradigm of treating patients with pulmonary arterial hypertension"
    Chazova, I. E.
    Martynyuk, T. V.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (03) : 114 - 116
  • [22] A RETROSPECTIVE DATABASE STUDY TO EVALUATE THE ECONOMIC BURDEN OF ILLNESS IN ENGLAND BASED ON A PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENT COHORT
    Beaudet, A.
    Yesufu-Udechuku, A.
    Davies, E. W.
    Taylor, L. H.
    Sikander-Rehman, S.
    Ogley, R.
    Hermans, R.
    Nordgren, A.
    Exposto, F.
    VALUE IN HEALTH, 2019, 22 : S352 - S352
  • [23] A RETROSPECTIVE DATABASE STUDY TO DEFINE A PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENT COHORT AND EVALUATE THE ECONOMIC BURDEN OF ILLNESS IN FRANCE
    Petrica, N.
    Beaudier, E.
    Beaudet, A.
    Exposto, F.
    VALUE IN HEALTH, 2018, 21 : S407 - S408
  • [24] Economic Burden Associated with Pulmonary Arterial Hypertension in the United States
    Watzker, Anna
    Alsumali, Adnan
    Ferro, Christine
    Dieguez, Gabriela
    Park, Clare
    Lautsch, Dominik
    El-Kersh, Karim
    PHARMACOECONOMICS, 2025, 43 (01) : 83 - 91
  • [25] ESTIMATION OF THE ECONOMIC AND SOCIAL BURDEN OF PULMONARY ARTERIAL HYPERTENSION IN SPAIN
    Zozaya, N.
    Abdalla, F.
    Casado Moreno, I
    Crespo Diz, C.
    Gallardo Ana, Ramirez M.
    Rueda Soriano, J.
    Alcala, M.
    Hidalgo Vega, A.
    VALUE IN HEALTH, 2022, 25 (01) : S53 - S53
  • [26] Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study
    Hoeper, Marius M.
    Corris, Paul A.
    Ghofrani, Hossein-Ardeschir
    Klinger, James R.
    Langleben, David
    Naeije, Robert
    Simonneau, Gerald
    Jansa, Pavel
    Rosenkranz, Stephan
    Grunig, Ekkehard
    Scelsi, Laura
    Meier, Christian
    Busse, Dennis
    Benza, Raymond L.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [27] Effect of Riociguat on Pulmonary Arterial Compliance in Patients With Pulmonary Arterial Hypertension (PAH) in the Respite Study
    Thenappan, Thenappan
    Hoeper, Marius
    Corris, Paul
    Ghofrani, Hossein-Ardeschir
    Klinger, James
    Langleben, David
    Naeije, Robert
    Simonneau, Gerald
    Jansa, Pavel
    Rosenkranz, Stephan
    Grunig, Ekkehard
    Scelsi, Laura
    Meier, Christian
    Busse, Dennis
    Benza, Raymond
    CHEST, 2017, 152 (04) : 1005A - 1006A
  • [28] Prevalence of Pulmonary Arterial Hypertension (PAH) in Patients With Idiopathic Pulmonary Fibrosis (IPF)
    Villar, Adolfo
    Ancochea, Julio
    Xaubet, Antonio
    CHEST, 2014, 145 (03)
  • [29] Association of delayed diagnosis of pulmonary arterial hypertension with its prognosis
    Kubota, Kayoko
    Miyanaga, Sunao
    Akao, Mitsumasa
    Mitsuyoshi, Kokoro
    Iwatani, Noriko
    Higo, Kenjuro
    Ohishi, Mitsuru
    JOURNAL OF CARDIOLOGY, 2024, 83 (06) : 365 - 370
  • [30] Targeted Therapy of pulmonary arterial Hypertension (PAH)
    Klose, H.
    Opitz, C.
    Bremer, H.
    Ewert, R.
    Bonderman, D.
    Rosenkranz, S.
    Seeger, W.
    Schmeisser, A.
    Harbaum, L.
    Buerke, M.
    Ghofrani, H. Ardeschir
    Borst, M. M.
    Leuchte, H. H.
    Lange, T. J.
    Behr, J.
    Ulrich, S.
    Lang, I.
    Olschewski, H.
    Gall, H.
    Kabitz, H. -J.
    Kleber, F. -X.
    Held, M.
    Hoeper, M. M.
    Gruenig, E.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S142 - S150
12345